MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-08-2026
Cumberland Pharmaceuticals ROA Ratio 2011-2026 | CPIX
Annual ROA Ratio Cumberland Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.84 | -2.52 | -7.7 | -2.63 | -4.56 | -3.46 | -3.38 | -6.18 | -8.56 | -1.01 | 0.8 | 2.54 | -2.4 | 5.93 | 5.92 | 2.67 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.93 | -8.56 | -1.65 |
Quarterly ROA Ratio Cumberland Pharmaceuticals
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.68 | -9.12 | -9.22 | -4.59 | -3.61 | -1.41 | -0.03 | -0.03 | -0.48 | -0.73 | -3.15 | -3.34 | -7.9 | -8.65 | -5.83 | -4.23 | -0.59 | 0.12 | -2.21 | -3.46 | -3.46 | -4.85 | -5.76 | -4.73 | -5.79 | -5.36 | -4.13 | -6.18 | -5.07 | -4.41 | -9.3 | -8.56 | -8.5 | -7.59 | -2.11 | -1.01 | -0.04 | -0.02 | 0.47 | 0.8 | 1.33 | 1.98 | 2.29 | 2.54 | 0.13 | -1.59 | -3.08 | -2.4 | 1.14 | 3.97 | 6.47 | 5.93 | 5.05 | 5.09 | 5.6 | 5.92 | 1.93 | 2.28 | 0.75 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.47 | -10.68 | -2.02 |
ROA Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
-47.69 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-30.55 | - | - | $ 36.6 M |  USA |
 |
HEXO Corp.
HEXO
|
-157.66 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-25.07 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-48.08 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-45.36 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-242.23 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-17.34 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-141.05 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-13.11 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-0.24 | $ 2.67 | -0.37 % | $ 1.02 B | Canada |
 |
Athenex
ATNX
|
-50.69 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
-1.29 | $ 39.05 | 3.75 % | $ 1.44 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-29.73 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-10.69 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
8.78 | - | -39.89 % | $ 27.7 M | USA |
 |
Canopy Growth Corporation
CGC
|
-65.18 | $ 1.01 | 1.5 % | $ 109 M | Canada |
 |
Organogenesis Holdings
ORGO
|
6.18 | $ 2.37 | 1.28 % | $ 300 M | USA |
 |
Pacira BioSciences
PCRX
|
-6.41 | $ 22.96 | -0.15 % | $ 1.06 B | USA |
 |
Aurora Cannabis
ACB
|
0.19 | $ 3.14 | 3.13 % | $ 172 M | Canada |
 |
Solid Biosciences
SLDB
|
-74.97 | $ 7.34 | 2.8 % | $ 642 M | USA |
 |
Jupiter Wellness
JUPW
|
-166.41 | - | - | $ 33.6 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-25.25 | $ 1.12 | 2.84 % | $ 1.39 M | USA |
 |
Lannett Company
LCI
|
-47.81 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-11.14 | $ 1.06 | -0.47 % | $ 101 M | Canada |
 |
Tilray
TLRY
|
-33.73 | $ 5.06 | 1.61 % | $ 3.13 B | Canada |
 |
Evolus
EOLS
|
-22.86 | $ 6.67 | -0.89 % | $ 430 M | USA |
 |
Sundial Growers
SNDL
|
-16.12 | $ 1.44 | 1.63 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
3.99 | $ 8.3 | -0.24 % | $ 444 M | USA |
 |
Veru
VERU
|
-76.17 | $ 3.07 | 2.43 % | $ 45 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-31.31 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
-19.59 | $ 0.71 | 3.49 % | $ 2.86 M | USA |
 |
Assertio Holdings
ASRT
|
-11.38 | $ 23.49 | 0.02 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
-24.62 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-38.66 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
0.6 | $ 5.08 | 0.4 % | $ 1.88 B | Canada |
 |
PetIQ
PETQ
|
0.25 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-61.05 | $ 6.72 | 1.05 % | $ 265 M | USA |
 |
Recro Pharma
REPH
|
-8.65 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-16.73 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-14.58 | $ 4.33 | 2.36 % | $ 216 M | USA |
 |
PLx Pharma
PLXP
|
-60.18 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
-9.45 | $ 16.46 | -0.12 % | $ 19.3 B | USA |
 |
Zomedica Corp.
ZOM
|
-64.44 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-63.1 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-9.3 | $ 0.65 | 3.92 % | $ 23.4 M | USA |
 |
Tricida
TCDA
|
-104.78 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-10.28 | $ 0.75 | 1.01 % | $ 3.22 M |  China |
 |
TherapeuticsMD
TXMD
|
-1.51 | $ 2.26 | 2.73 % | $ 26.1 M | USA |